Found: 14
Select item for more details and to access through your institution.
The bispecific B7H3xCD3 antibody CC-3 induces T cell immunity against bone and soft tissue sarcomas.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1391954
- By:
- Publication type:
- Article
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01050-6
- By:
- Publication type:
- Article
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4126, doi. 10.3390/ijms25074126
- By:
- Publication type:
- Article
Immunocytokines with target cell–restricted IL-15 activity for treatment of B cell malignancies.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 737, p. 1, doi. 10.1126/scitranslmed.adh1988
- By:
- Publication type:
- Article
An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1343929
- By:
- Publication type:
- Article
Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13156, doi. 10.3390/ijms241713156
- By:
- Publication type:
- Article
B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1002898
- By:
- Publication type:
- Article
IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3941, doi. 10.3390/cancers14163941
- By:
- Publication type:
- Article
Identification of CD105 (endoglin) as novel risk marker in CLL.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 4, p. 773, doi. 10.1007/s00277-022-04756-4
- By:
- Publication type:
- Article
CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4596, doi. 10.3390/cancers13184596
- By:
- Publication type:
- Article
Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.653081
- By:
- Publication type:
- Article
An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 2, p. 1, doi. 10.15252/emmm.201911902
- By:
- Publication type:
- Article
CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Identification of CD318 (CDCP1) as novel prognostic marker in AML.
- Published in:
- 2020
- By:
- Publication type:
- journal article